UroGen Pharma Ltd. Short-term Investments
UroGen Pharma Ltd. (URGN) had Short-term Investments of $30.16 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:ShortTermInvestments · last filed 2026-08-05
- 2026-06-30: Short-term Investments $30.16M.
- 2026-03-31: Short-term Investments $39.74M.
- 2025-12-31: Short-term Investments $49.31M.
- 2025-09-30: Short-term Investments $63.79M.
| Period end | Short-term Investments |
|---|---|
| 2026-06-30 | $30.16M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $39.74M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $49.31M 10-K · filed 2026-03-02 |
| 2025-09-30 | $63.79M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $83.11M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $112.03M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $110.67M 10-K · filed 2026-03-02 |
| 2024-09-30 | $153.93M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $52.28M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $51.72M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $56.16M 10-K · filed 2025-03-10 |
| 2023-09-30 | $55.30M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $35.89M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $39.38M 10-Q · filed 2023-05-11 |
| 2017-12-31 | $36.00M 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |